Auna Announces 3Q26 Financial Results
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Auna reports
LUXEMBOURG--(BUSINESS WIRE)--
Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in
3Q’26 Consolidated Highlights
-
Revenue increased
10% YoY FXN and19% YoY as reported to S/1,325 million, with sequential growth of3% FXN and7% as reported -
Adjusted EBITDA was S/231 million, decreasing
4.6% FXN while remaining flat as reported. Sequentially, Adjusted EBITDA was stable FXN and increased2% as reported -
Mexico Segment Adjusted EBITDA increased
5% YoY in local currency, marking its first year-over-year growth in 2026 -
Adjusted EBITDA Margin of
17.5% , compared to18.4% in 2Q26 -
Year to date Net Cash from Operating Activities increased
62% YoY to S/713 million, while Free Cash Flow increased95% to S/626 million -
Leverage
Ratio improved to 3.5x -
Oncology MLR remained stable at
50.7% -
Number of surgeries increased
12% YoY to 23,932 -
Number of days hospitalized increased
6% YoY to 144,041 -
Number of chemotherapy and radiotherapy sessions increased
7% YoY
Message from Auna’s Executive Chairman and President
The third quarter of 2026 reflected continued strong commercial momentum across our markets, with revenue increasing
In
In
In
Consolidated cash flow generation remained a significant strength of our platform. Year-to-date Net Cash from Operating activities increased
We reached an important milestone with the commencement of construction of Centro Ambulatorio Trecca in
Looking ahead, as discussed at our recent 2026 Investor Day, we remain confident in the underlying growth trajectory of our business. We reaffirm our full-year 2026 revenue guidance, expecting FX-neutral growth within our
We remain focused on accelerating growth in
Overview of 3Q26 Consolidated Results
Revenues increased
Adjusted EBITDA decreased
Reported results were impacted by foreign exchange fluctuations, including a
Net finance costs were S/112 million in 3Q26, compared to S/72 million in 3Q25. The increase primarily reflected a S/40 million non-cash FX gain recognized in 3Q25 that did not recur in 3Q26, due to Auna resetting its USD/PEN call spread to 3.40-3.80 in Q425. The remainder of the change was due to an increase in Finance costs consisting of (i) a S/6 million non-cash finance expense related to the future purchase obligation for IMAT Oncomedica in 3Q26 versus S/1 million in 3Q25; and (ii) Interest expense and other costs of S/114 in 3Q26 versus S/115 in 3Q25, and partially offset by Finance income of S/7 million in 3Q26 versus S/4 million in 3Q25. Excluding non-cash effects, Net finance costs were S/107 million in 3Q26, compared to S/110 million in 3Q25.
Net Income was S/24 million in 3Q26, compared to S/53 million in 3Q25 primarily reflecting the absence of the significant S/40 million non-cash FX gain recorded in the prior-year period, partially offset by S/20 million in lower income tax expenses. On a per-share basis, Net Income was S/0.27, based on a weighted average of 74,235,734 basic and diluted shares.
Adjusted Net Income was S/35 million in 3Q26, compared to S/58 million in 3Q25, primarily reflecting the non-cash FX effects described above, partially offset by lower income tax expenses. On a per-share basis, Adjusted Net Income was S/0.41, based on a weighted average of 74,235,734 basic and diluted shares.
For a full version of AUNA’s Third Quarter 2026 Earnings Release, please visit:
https://aunainvestors.com/English/financial-information/quarterly-results/
Conference Call Details
When: 8:00 a.m. Eastern time, November 18, 2026
Who: Mr. Suso Zamora, Executive Chairman of the Board and President; Mrs. Gisele Remy, Chief Financial Officer and Executive Vice President; Mr. Lorenzo Massart, Executive Vice President of Strategy and Equity Capital Markets.
Dial-in: +1 833-461-5787 (
Passcode: 489 711 788
To access Auna′s financial results call via telephone, callers need to press # to be connected to an operator.
Webcast: click here
About AUNA
Auna is a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, prioritizing prevention and concentrating on high-complexity diseases that contribute the most to healthcare expenditures. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-Speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of September 30, 2026, Auna’s network included 31 healthcare network facilities, consisting of hospitals, outpatient, prevention and wellness facilities with a total of 2,361 beds, and 1.4 million healthcare plans.
For more information visit www.aunainvestors.com.
Safe Harbor Statement
This press release contains forward-looking statements. Forward-looking statements convey our current expectations or forecasts of future events. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to differ materially from the forward-looking statements that we make. Forward-looking statements typically are identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “project,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” or other similar expressions. Forward-looking statements that appear in a number of places in this press release include, but are not limited to, statements regarding the intent, belief or current expectations, regarding various matters, including, our target Leverage Ratio, the results of the key initiatives we are implementing in Mexico, Colombia and Peru, the execution of our strategic plan, including the recovery of our growth levels, our planned investments, our revenue, Adjusted EBITDA and capital expenditure guidance, our expectation for revenue and Adjusted EBITDA growth, the timeline for the construction and commencement of operations at the Centro Ambulatorio Trecca in Lima and our ability to recover any loss under the oncology risk-sharing contract in Colombia. Any or all of our forward-looking statements in this press release may turn out to be inaccurate. Our actual results could differ materially from those contained in forward-looking statements due to a number of factors.
The forward-looking statements in this press release represent our expectations and forecasts as of the date of this press release. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release. For a discussion of the risks facing the Company which could affect whether these forward-looking statements are realized, see our Form 20-F filing with the U.S. Securities and Exchange Commission (the “SEC”).
Financial Guidance Disclaimer
Auna′s guidance is based on management’s current performance outlook and expected macroeconomic and regulatory conditions in the three countries where the Company operates. Any changes in these conditions could have an impact on the guidance provided.
Auna’s financial guidance reflects management’s current assumptions regarding numerous evolving factors that are difficult to accurately predict, including those discussed in the Risk Factors set forth in the Company’s Form 20-F filed with the SEC. Reconciliations of forward-looking non-IFRS measures, specifically the Leverage Ratio target and Adjusted EBITDA guidance, to the relevant forward-looking IFRS measures are not being provided, as the Company does not currently have sufficient data to accurately estimate the variables and individual adjustments for such guidance and reconciliations. Due to this uncertainty, the Company cannot reconcile projected Adjusted EBITDA to projected net income without unreasonable effort. The financial guidance constitutes forward-looking statements. For more information, see the “Safe Harbor Statement” section in this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261117170113/en/
IR Contact
Email: contact@aunainvestors.com
Source: Auna S.A.